Phase 3 Ataxia Clinical Trials

3 recruitingPhase 3

What is a Phase 3 trial?

Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.

Showing 1–3 of 3 trials

Recruiting

Phase 3

A Study to Learn More About the Effects and Long-Term Safety of BIIB141 (Omaveloxolone) in Participants With Friedreich's Ataxia Aged 2 to 15 Years Old (BRAVE)

Friedreich Ataxia

Biogen255 enrolled34 locationsNCT06953583

Recruiting

Phase 3

A Randomized, Parallel-arm, Double Blind, Placebo-controlled Study to Assess the Efficacy of Fampridine for Patients With Spinocerebellar Ataxia SCA27B Caused by a GAA Expansion in the FGF14 Gene

Spinocerebellar Ataxia 27B (SCA27B)

Assistance Publique - Hôpitaux de Paris70 enrolled9 locationsNCT07185347

Not Yet Recruiting

Phase 2Phase 3

Pregabalin for the treatment of Cerebellar Ataxia with Neuropathy and Vestibular Areflexia Syndrome (CANVAS) associated chronic cough.

Cerebellar Ataxia with Neuropathy and Vestibular Areflexia Syndrome (CANVAS)chronic cough

Richard Roxburgh18 enrolled1 locationACTRN12623001356651